Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RPh201 in Partial Thickness Burn
NCT01455480Phase 2Withdrawn
- Sponsor
- Regenera Pharma
- Start
- Dec 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RPh201 in partial-thickness burn, sponsored by Regenera Pharma. Planned start Dec 2011; status: withdrawn.
02
Drugs
RPh201
03
Conditions
partial-thickness burn
Beyond the preview
Go deeper on NCT01455480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01455480.